Cidara is developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing cancers and other serious diseases. The Company’s proprietary Cloudbreak® platform enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system.
Cidara is headquartered in San Diego, California and is built on the core values of collaboration, integrity, accountability, urgency and courage which foster a unique and award-winning atmosphere.